Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20494931rdf:typepubmed:Citationlld:pubmed
pubmed-article:20494931lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C0239307lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C0026986lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C0280449lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C1831743lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C0023981lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C1522609lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C1554112lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C0205088lld:lifeskim
pubmed-article:20494931lifeskim:mentionsumls-concept:C1515895lld:lifeskim
pubmed-article:20494931pubmed:issue10lld:pubmed
pubmed-article:20494931pubmed:dateCreated2010-10-4lld:pubmed
pubmed-article:20494931pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:abstractTextAllogeneic stem cell transplantation is usually considered the only curative treatment option for patients with advanced or transformed myelodysplastic syndromes in complete remission, but post-remission chemotherapy and autologous stem cell transplantation are potential alternatives, especially in patients over 45 years old.lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:languageenglld:pubmed
pubmed-article:20494931pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20494931pubmed:citationSubsetIMlld:pubmed
pubmed-article:20494931pubmed:statusMEDLINElld:pubmed
pubmed-article:20494931pubmed:monthOctlld:pubmed
pubmed-article:20494931pubmed:issn1592-8721lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:AmadoriSergio...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:HagemeijerAnn...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:WillemzeRoelRlld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:MarieJean-Pie...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:DelforgeMiche...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:GratwohlAlois...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:SuciuStefanSlld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:Hellström-Lin...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:de WitteTheoTlld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:JansenJoop...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:SchoutenHarry...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:MuusPetraPlld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:SelleslagDomi...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:WijermansPier...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:FerrantAugust...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:KobbeGuidoGlld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:KovacsovicsTi...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:BiersackHaral...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:OssenkoppeleG...lld:pubmed
pubmed-article:20494931pubmed:authorpubmed-author:BelhabriAminAlld:pubmed
pubmed-article:20494931pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20494931pubmed:volume95lld:pubmed
pubmed-article:20494931pubmed:ownerNLMlld:pubmed
pubmed-article:20494931pubmed:authorsCompleteYlld:pubmed
pubmed-article:20494931pubmed:pagination1754-61lld:pubmed
pubmed-article:20494931pubmed:meshHeadingpubmed-meshheading:20494931...lld:pubmed
pubmed-article:20494931pubmed:meshHeadingpubmed-meshheading:20494931...lld:pubmed
pubmed-article:20494931pubmed:meshHeadingpubmed-meshheading:20494931...lld:pubmed
pubmed-article:20494931pubmed:meshHeadingpubmed-meshheading:20494931...lld:pubmed
pubmed-article:20494931pubmed:meshHeadingpubmed-meshheading:20494931...lld:pubmed
pubmed-article:20494931pubmed:meshHeadingpubmed-meshheading:20494931...lld:pubmed
pubmed-article:20494931pubmed:meshHeadingpubmed-meshheading:20494931...lld:pubmed
pubmed-article:20494931pubmed:meshHeadingpubmed-meshheading:20494931...lld:pubmed
pubmed-article:20494931pubmed:meshHeadingpubmed-meshheading:20494931...lld:pubmed
pubmed-article:20494931pubmed:meshHeadingpubmed-meshheading:20494931...lld:pubmed
pubmed-article:20494931pubmed:meshHeadingpubmed-meshheading:20494931...lld:pubmed
pubmed-article:20494931pubmed:year2010lld:pubmed
pubmed-article:20494931pubmed:articleTitleValue of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.lld:pubmed
pubmed-article:20494931pubmed:affiliationDepartment of Tumorimmunology, Radboud University Medical Centre Nijmegen, Nijmegen, the Netherlands. t.deWitte@ncmls.ru.nllld:pubmed
pubmed-article:20494931pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20494931pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:20494931pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:20494931pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20494931pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20494931lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20494931lld:pubmed